G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update

    NEXT STORY
    Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference
    PREV STORY
    Cytokinetics Reports First Quarter 2020 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Oasmia Pharmaceutical AB (publ) Delårsrapport för perioden maj – oktober 2018

    ANDRA KVARTALET 1 augusti – 31 oktober 2018 Koncernens nettoomsättning uppgick till 158 tkr ...

    author_avatar
    NASDAQ Market News

    Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

    LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter ...

    author_avatar
    NASDAQ Market News

    Sorrento Establishes Business Unit to Address Market Opportunity for Proprietary Water Soluble Cannabidiol (CBD) Formulations

    author_avatar
    NASDAQ Market News